|
Volumn 28, Issue 21, 2007, Pages 2685-
|
STEMI and NSTEMI are two distinct pathophysiological entities [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
BLOOD CLOTTING FACTOR 7;
TISSUE PLASMINOGEN ACTIVATOR;
BLOOD CLOT LYSIS;
EVIDENCE BASED MEDICINE;
HEART INFARCTION;
HOSPITALIZATION;
HUMAN;
LETTER;
PATHOPHYSIOLOGY;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
PROGNOSIS;
RECURRENT DISEASE;
SMOKING CESSATION;
ST SEGMENT ELEVATION;
TREATMENT FAILURE;
ELECTROCARDIOGRAPHY;
FIBRINOLYTIC THERAPY;
HEART MUSCLE REPERFUSION;
MORTALITY;
NOTE;
TREATMENT OUTCOME;
ELECTROCARDIOGRAPHY;
HUMANS;
MYOCARDIAL INFARCTION;
MYOCARDIAL REPERFUSION;
THROMBOLYTIC THERAPY;
TREATMENT OUTCOME;
|
EID: 35948941871
PISSN: 0195668X
EISSN: 15229645
Source Type: Journal
DOI: 10.1093/eurheartj/ehm368 Document Type: Letter |
Times cited : (11)
|
References (5)
|